test

James Silverman

@Opaleye Management Inc.

Latest period2024 - Q3ReportedManaged Assets$599.558MTotal holdings44
Assets growth rate37%Assets growth rate (2-Q avg)16.19%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Opaleye Management Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 44 positions.

Assets under management

The assets under management (AUM) of Opaleye Management Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 599.558M in assets, with a quarterly growth rate of 37% and a 2-quarter average growth rate of 16.19%. The portfolio is managed by James Silverman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
EWTXEdgewise Therapeutics Inc
Recent Activity
Decreased -9.91%
2.33%
$13.946M
522,500 shares@ $26.69 avg price
CRGXCargo Therapeutics Inc
Recent Activity
Decreased -2.56%
1.98%
$11.835M
541,437 shares@ $21.86 avg price
APLTApplied Therapeutics Inc'
Recent Activity
Decreased -21.42%
1.88%
$11.22M
1.32M shares@ $8.5 avg price
PCVXVaxcyte Inc
Recent Activity
1.63%
$9.713M
85,000 shares@ $114.27 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Increased 0.26%
1.58%
$9.437M
420,000 shares@ $22.47 avg price
SLRNAcelyrin Inc
Recent Activity
Increased 19.86%
1.56%
$9.336M
1.894M shares@ $4.94 avg price
TRVITrevi Therapeutics Inc
Recent Activity
Decreased -2.91%
1.44%
$8.577M
2.568M shares@ $3.35 avg price
BDSXBiodesix Inc
Recent Activity
Decreased -5.09%
1.17%
$6.971M
3.815M shares@ $1.83 avg price
DNAGinkgo Bioworks Holdings
Recent Activity
New Position
1.12%
$6.685M
820,202 shares@ $8.15 avg price
JSPRJasper Therapeutics Inc
Recent Activity
Decreased -9.82%
1.11%
$6.649M
353,500 shares@ $18.81 avg price